摘要
目的:分析在小儿肺炎当中应用头孢克肟颗粒联合氨溴特罗口服液治疗的临床效果.方法:选择2021年1月至2022年1月期间来我院接受治疗的小儿肺炎患儿作为研究样本,纳入80例,经双盲法分入实验组与参照组当中,各40例,实验组接受氨溴特罗口服液联合头孢克肟颗粒治疗,参照组患儿接受氨溴特罗口服液单独治疗,对两组患儿治疗前后肺功能指标(呼吸流量峰值、用力肺活量、第一秒用力呼气容积)、症状消失时间(发热、咳嗽、肺部啰音、气促)、不良反应发生率(乏力、头晕、恶心呕吐)进行展开分析与讨论.结果:治疗前,比较两组患儿的肺功
Abstract
Objective To analyze the clinical effect of cefixime granules combined with ambroxol oral liquid in the treatment of pediatric pneumonia. Methods: 80 children with pediatric pneumonia who came to our hospital for treatment from January 2021 to January 2022 were selected as the study samples, and were divided into the experimental group and the reference group by double blind method, with 40 cases in each group. The experimental group received ambroxol oral liquid combined with cefixime granules, and the reference group received ambroxol oral liquid alone, The pulmonary function indexes (peak respiratory flow, forced vital capacity, forced expiratory volume in the first second), the time of symptom disappearance (fever, cough, lung rale, shortness of breath), After treatment, from the aspect of lung function indicators, the experimental group was higher than the reference group (P＜0.05); From the aspect of symptom disappearance time, the experimental group was shorter than the reference group (P＜0.05); There was no significant difference in the incidence of adverse reactions between the two groups (P＞0.05). Conclusion: In the clinical treatment of children with pneumonia, the application of cefixime granules combined with ambroxol oral liquid has a significant effect, can improve the pulmonary function indicators of children, promote the recovery of children, and has high safety, which is worth promoting.
万方数据